Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 512


Chordoma: The Quest for Better Treatment Options.

Heery CR.

Oncol Ther. 2016;4(1):35-51. doi: 10.1007/s40487-016-0016-0. Review.


Microsporidia infection impacts the host cell's cycle and reduces host cell apoptosis.

Martín-Hernández R, Higes M, Sagastume S, Juarranz Á, Dias-Almeida J, Budge GE, Meana A, Boonham N.

PLoS One. 2017 Feb 2;12(2):e0170183. doi: 10.1371/journal.pone.0170183.


NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.

Cui X, Shen D, Kong C, Zhang Z, Zeng Y, Lin X, Liu X.

Sci Rep. 2017 Jan 31;7:40723. doi: 10.1038/srep40723.


Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis.

Chen M, Wu J, Zhang XX, Wang Q, Yan SH, Wang HD, Liu SL, Zou X.

Oncol Lett. 2017 Jan;13(1):370-376. doi: 10.3892/ol.2016.5404.


Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.

Fan B, Kang L, Chen L, Sun P, Jin M, Wang Q, Bae YH, Huang W, Gao Z.

Theranostics. 2017 Jan 1;7(2):357-376. doi: 10.7150/thno.16855.


CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer.

Yang K, Gao K, Hu G, Wen Y, Lin C, Li X.

Onco Targets Ther. 2016 Nov 30;9:7285-7295.


Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Jakubowska K, Pryczynicz A, Dymicka-Piekarska V, Famulski W, Guzińska-Ustymowicz K.

Oncol Lett. 2016 Nov;12(5):3591-3597.


Corosolic acid inhibits the proliferation of osteosarcoma cells by inducing apoptosis.

Jia Y, Yuan H, Shan S, Xu G, Yu J, Zhao C, Mou X.

Oncol Lett. 2016 Nov;12(5):4187-4194.


Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.

Cheng KY, Wang ZL, Gu QY, Hao M.

PLoS One. 2016 Oct 20;11(10):e0165117. doi: 10.1371/journal.pone.0165117.


Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.

Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD.

Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352.


A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles.

Beghein E, Van Audenhove I, Zwaenepoel O, Verhelle A, De Ganck A, Gettemans J.

Sci Rep. 2016 Aug 12;6:31177. doi: 10.1038/srep31177.


hTERT and BIRC5 gene promoters for cancer gene therapy: A comparative study.

Shepelev MV, Kopantzev EP, Vinogradova TV, Sverdlov ED, Korobko IV.

Oncol Lett. 2016 Aug;12(2):1204-1210.


mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture.

Kim TH, Chang JH, Lee HJ, Kim JA, Lim YS, Kim CW, Han SW.

Medicine (Baltimore). 2016 Jul;95(27):e4132. doi: 10.1097/MD.0000000000004132.


Survivin: a unique target for tumor therapy.

Garg H, Suri P, Gupta JC, Talwar GP, Dubey S.

Cancer Cell Int. 2016 Jun 23;16:49. doi: 10.1186/s12935-016-0326-1. Review.


Delivery strategies and potential targets for siRNA in major cancer types.

Lee SJ, Kim MJ, Kwon IC, Roberts TM.

Adv Drug Deliv Rev. 2016 Sep 1;104:2-15. doi: 10.1016/j.addr.2016.05.010. Review.


Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study.

Lin KY, Cheng SM, Tsai SL, Tsai JY, Lin CH, Cheung CH.

Onco Targets Ther. 2016 May 3;9:2601-13. doi: 10.2147/OTT.S101209.


Experimental study on inhibition of the growth of human adenoid cystic cancer cells by RNA interference targeting against survivingene.

Wang X, Xiong Y, Zhang C, Zhou J, Yang J, Wang K, Xia X.

Am J Transl Res. 2016 Feb 15;8(2):375-83.

Supplemental Content

Support Center